학술논문
Treatment with the Bcl-xL inhibitor ABT-737 in combination with interferon α specifically targets JAK2V617F-positive polycythemia vera hematopoietic progenitor cells
Document Type
Short Communication
Author
Source
In Blood 18 November 2010 116(20):4284-4287
Subject
Language
ISSN
0006-4971